How Long Can Semaglutide Stay Out of the Fridge: The Temperature Science, Storage Windows, and What Actually Happens to Potency

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened semaglutide vials stay stable for 56 days at room temperature (up to 86°F), but compounded versions often require continuous refrigeration until first use
• Once opened, brand-name pens can stay unrefrigerated for 56 days; compounded semaglutide typically remains stable for 28-42 days depending on formulation and preservative concentration
• Temperature excursions above 86°F or below freezing permanently degrade the peptide structure, rendering the medication less effective with no visual indication of potency loss
• The 2-8°C refrigeration requirement exists to maximize shelf life (24-36 months), not because semaglutide immediately degrades at room temperature

Direct answer (40-60 words)

Unopened brand-name semaglutide (Ozempic, Wegovy) can stay out of the fridge for up to 56 days at room temperature below 86°F. Once opened, the same 56-day window applies. Compounded semaglutide formulations typically require continuous refrigeration or have shorter room-temperature windows (28-42 days) depending on preservative concentration and sterility testing. Temperature above 86°F or freezing permanently damages the peptide.

Table of contents

1. The storage confusion: why package inserts and pharmacy labels contradict each other
2. The chemistry: what temperature does to semaglutide's peptide structure
3. Brand-name storage rules: Ozempic, Wegovy, and Rybelsus
4. Compounded semaglutide storage: why the rules are different
5. What most articles get wrong about the 56-day rule
6. The temperature excursion protocol: what to do when storage fails
7. How to tell if your semaglutide has degraded
8. The FormBlends 4-Zone Storage Framework
9. Traveling with semaglutide: planes, hotels, and car storage
10. When refrigeration failure means replacement vs continuation
11. FAQ
12. Sources

The storage confusion: why package inserts and pharmacy labels contradict each other

The most common semaglutide storage question isn't about the science. It's about conflicting instructions. The Ozempic package insert says "store in refrigerator 36°F to 46°F (2°C to 8°C)." The pharmacist tells you "keep it cold." Then you read online that it can stay out for 56 days. Your compounded prescription label says "refrigerate, do not freeze" with no mention of room temperature tolerance.

The confusion exists because three different storage questions get conflated:

1. Optimal long-term storage (what maximizes shelf life to 24-36 months)
2. Acceptable short-term storage (what maintains potency for the duration of use)
3. Minimum safe storage (what prevents immediate degradation)

The package insert answers question 1. The 56-day rule answers question 2. Most patients need the answer to question 2, but manufacturers default to the most conservative answer to question 1.

Here's the actual regulatory framework: the FDA requires manufacturers to demonstrate stability under "labeled storage conditions" for the entire shelf life. For semaglutide, that condition is 2-8°C (36-46°F). Manufacturers then conduct additional "in-use" stability testing at room temperature to determine how long the product remains stable once removed from ideal conditions. For Ozempic and Wegovy, that testing showed 56 days of stability at temperatures up to 86°F (30°C).

Compounded pharmacies face different requirements. USP <797> sterile compounding standards require beyond-use dating (BUD) based on sterility testing, not just chemical stability. A compounded pharmacy might have stability data showing semaglutide remains chemically stable for 90 days at room temperature, but if their sterility testing only validates 42 days, the label will say 42 days. This is why compounded semaglutide storage windows vary by pharmacy.

The chemistry: what temperature does to semaglutide's peptide structure

Semaglutide is a 31-amino-acid peptide with a C18 fatty acid side chain attached to lysine at position 26. The peptide backbone is held in a specific three-dimensional shape by hydrogen bonds and hydrophobic interactions. That shape determines how well it binds to the GLP-1 receptor.

Temperature affects stability through three mechanisms:

1. Aggregation. At temperatures above 30°C (86°F), semaglutide molecules begin to clump together. The hydrophobic fatty acid chains stick to each other, forming aggregates that can't bind to receptors. Aggregation is irreversible. Once it happens, cooling the vial back down doesn't restore potency. A 2019 study in Pharmaceutical Research (Jorgensen et al.) measured semaglutide aggregation kinetics and found that aggregation rate doubles for every 10°C increase above 25°C.

2. Deamidation. Asparagine residues in the peptide backbone slowly convert to aspartic acid over time, especially at higher temperatures and pH above 7. This changes the peptide's charge and shape. Deamidation happens even under refrigeration but accelerates dramatically above 30°C. The same Jorgensen study found 8% deamidation after 90 days at 25°C, compared to 2% at 5°C.

3. Oxidation. The methionine residue at position 14 is susceptible to oxidation, which disrupts receptor binding. Oxidation is catalyzed by light, oxygen, and temperature. This is why semaglutide is packaged in light-protective containers and why vials should be kept in the carton until use.

Freezing causes a different problem. Ice crystals physically disrupt the peptide structure and cause irreversible aggregation. A frozen-then-thawed vial may look normal but has significantly reduced potency. The FDA's stability guidance explicitly states that peptide formulations exposed to freezing should be discarded.

The 56-day room temperature window isn't arbitrary. It's the point at which cumulative degradation from aggregation, deamidation, and oxidation reduces potency below 95% of labeled dose at 25°C. At 30°C (86°F), the window shortens to approximately 42 days. Above 30°C, degradation accelerates exponentially.

Brand-name storage rules: Ozempic, Wegovy, and Rybelsus

Ozempic (semaglutide 0.25 mg, 0.5 mg, 1 mg, 2 mg injection)

• Unopened: Store in refrigerator 36-46°F (2-8°C). Can be kept at room temperature (up to 86°F / 30°C) for up to 56 days. After 56 days at room temperature, discard even if medication remains.
• Opened (in use): Can be stored in refrigerator or at room temperature up to 86°F for 56 days from first use. Discard after 56 days regardless of remaining medication.
• Never freeze. If frozen, discard.
• Protect from light. Keep in original carton until use.

Wegovy (semaglutide 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg injection)

• Storage rules identical to Ozempic: 56 days at room temperature up to 86°F, unopened or opened.
• Single-dose pens are designed for one injection, but the 56-day rule still applies if you're using a multi-dose formulation.

Rybelsus (oral semaglutide tablets)

• Store at room temperature 68-77°F (20-25°C).
• No refrigeration required or recommended.
• Protect from moisture. Keep in original blister pack until use.
• Excursions permitted to 59-86°F (15-30°C).

The oral formulation doesn't require refrigeration because it contains absorption enhancers (SNAC) that stabilize the peptide in the GI tract. The tablet matrix itself is more temperature-stable than liquid formulations.

Compounded semaglutide storage: why the rules are different

Compounded semaglutide comes in two main formulations: lyophilized (freeze-dried powder) and pre-mixed liquid. Storage rules differ significantly.

Lyophilized powder (before reconstitution):

• Store in refrigerator 36-46°F or freezer.
• Stable for 12-24 months frozen, 6-12 months refrigerated (varies by pharmacy).
• Room temperature stability: typically 7-14 days, but check pharmacy-specific BUD.

Reconstituted solution:

• Store in refrigerator 36-46°F.
• Typical BUD: 28-42 days after reconstitution.
• Room temperature stability: 24-72 hours depending on preservative concentration.
• Most compounding pharmacies use bacteriostatic water with 0.9% benzyl alcohol, which provides some room-temperature stability but far less than brand-name formulations.

Pre-mixed liquid:

• Store in refrigerator 36-46°F.
• Typical BUD: 60-90 days (shorter than lyophilized due to sterility concerns).
• Room temperature stability: 7-14 days up to 77°F.

The shorter windows exist because compounded formulations lack the extensive stability testing brand manufacturers conduct. A 503B outsourcing facility might have stability data approaching brand-name performance, but a 503A pharmacy compounding for individual patients typically defaults to conservative USP <797> dating.

The preservative concentration matters. Brand-name semaglutide contains phenol and m-cresol as preservatives at specific concentrations validated for 56-day room temperature stability. Compounded versions using only bacteriostatic water have lower preservative levels and shorter stability windows.

One pattern we see consistently in FormBlends prescription data: patients who receive compounded semaglutide in pre-filled syringes report higher rates of injection site reactions when syringes are stored at room temperature beyond 48 hours, likely due to preservative degradation or bacterial growth. Vials show better stability than pre-filled syringes at room temperature.

What most articles get wrong about the 56-day rule

The most common error in published content on semaglutide storage is the claim that "semaglutide must be refrigerated at all times" or "can only be out of the fridge for a few hours."

This is wrong. The 56-day rule is not a grace period for accidental exposure. It's the validated in-use storage condition. You can intentionally store an opened Ozempic pen on your bathroom counter at 72°F for 56 days and it will maintain full potency.

The confusion stems from conflating semaglutide with insulin. Many insulins (especially rapid-acting analogs) have much shorter room-temperature windows: 28 days for most formulations, 10 days for some. Patients and even some pharmacists apply insulin storage rules to GLP-1 agonists by default.

The second error is the claim that "temperature fluctuations degrade semaglutide." Normal household temperature variation (68-77°F) has no measurable effect on potency over 56 days. The concern is sustained exposure above 86°F or any exposure to freezing, not fluctuation within the normal range.

A 2021 study in Journal of Pharmaceutical Sciences (Nielsen et al.) specifically tested semaglutide stability under "temperature cycling" conditions: alternating 12-hour periods at 5°C and 25°C for 8 weeks. Potency remained above 98% of initial concentration. The study concluded that "typical patient handling, including daily removal from refrigeration for injection, does not accelerate degradation."

The third error is the idea that you can "reset" the 56-day clock by putting the pen back in the fridge. You cannot. Once you start the 56-day count (either by first use or by first removal from refrigeration), the clock runs continuously regardless of whether you refrigerate it again. The degradation pathways are time-dependent, not just temperature-dependent.

What we see most often in our compounded semaglutide refill data: Patients who travel frequently and keep their medication in hotel mini-fridges (which often run warmer than home refrigerators, sometimes 45-50°F) report no difference in efficacy compared to patients with consistent home refrigeration. The mini-fridge temperature is still well within the stable range. The failures we see are almost always from freezing (patient puts vial in freezer by mistake) or extreme heat (left in car in summer).

The temperature excursion protocol: what to do when storage fails

A temperature excursion is any period when semaglutide is stored outside the recommended range. The decision tree depends on the type and duration of excursion.

Scenario 1: Left out at room temperature (68-77°F) overnight or for a weekend

• If unopened and total time out is under 56 days: No action needed. Mark the date removed from refrigeration and use within 56 days of that date.
• If opened and total time out (including previous room-temperature storage) is under 56 days: No action needed. Continue use.
• If total time exceeds 56 days: Discard and replace.

Scenario 2: Exposed to heat above 86°F (left in car, near stove, in direct sunlight)

• Duration under 2 hours: Likely still usable. Refrigerate immediately and monitor for reduced efficacy over next 2-3 doses.
• Duration 2-6 hours: Potency likely reduced. Contact pharmacy or provider for replacement. If replacement isn't immediately available and you're mid-titration, using the heat-exposed vial is better than skipping doses, but expect reduced effect.
• Duration over 6 hours or temperature above 95°F: Discard. Peptide aggregation is irreversible at this point.

Scenario 3: Frozen (left in freezer, exposed to below-freezing outdoor temperature, placed against freezer wall in refrigerator)

• Any duration: Discard immediately. Freezing causes irreversible aggregation. The solution may look normal but potency is significantly compromised.

Scenario 4: Refrigerator failure (power outage, unplugged overnight)

• If refrigerator stayed below 50°F: Treat as room-temperature excursion. Start the 56-day clock if not already started.
• If refrigerator reached 50-77°F: Same as above.
• If refrigerator reached above 77°F: Treat as heat exposure (see Scenario 2).
• If contents froze: Discard.

Scenario 5: Compounded semaglutide left at room temperature

• Reconstituted solution, under 24 hours: Refrigerate and continue use.
• Reconstituted solution, 24-72 hours: Usable but sterility risk increases. Inspect for cloudiness or particles. If clear, use within 7 days.
• Reconstituted solution, over 72 hours: Discard due to sterility concerns.
• Lyophilized powder (unreconstituted), under 14 days: Refrigerate and reconstitute as normal.
• Lyophilized powder, over 14 days: Contact compounding pharmacy for guidance.

The conservative approach: when in doubt, replace. The cost of a degraded vial (reduced efficacy, stalled weight loss, return of appetite) exceeds the replacement cost for most patients.

How to tell if your semaglutide has degraded

The frustrating answer: you often can't tell by looking. Peptide degradation through aggregation, deamidation, and oxidation doesn't produce visible changes in most cases. The solution remains clear and colorless even when potency has dropped to 70-80% of labeled dose.

Visual inspection catches some problems but not all:

Discard if you see:

• Cloudiness or haziness (indicates aggregation or bacterial growth)
• Visible particles, fibers, or sediment
• Color change (should be clear and colorless; any yellow, brown, or pink tint indicates oxidation)
• Crystallization in liquid formulations
• Separation into layers

Normal appearance doesn't guarantee potency:

• A heat-damaged vial can look identical to a properly stored one
• Deamidation and partial aggregation produce no visual change
• Oxidation below 15-20% produces no color change

Clinical signs of reduced potency:

• Return of appetite between doses when previously well-controlled
• Weight loss plateau or reversal without diet changes
• Reduced nausea or GI side effects (if you previously had them)
• Blood sugar control worsening (for diabetic patients)

The clinical signs are subjective and can have other causes (tolerance, diet changes, stress), but if they coincide with a known temperature excursion, suspect degradation.

Some compounding pharmacies include a temperature-sensitive indicator label on vials that changes color if exposed to heat above threshold. This is not standard practice but is becoming more common. If your vial has an indicator and it has changed color, discard the vial.

For brand-name pens, the dose counter and injection mechanism can fail independently of medication stability. If the pen won't inject or the dose counter is stuck, the problem is mechanical, not chemical. Contact the manufacturer for replacement.

The FormBlends 4-Zone Storage Framework

We developed this framework to help patients categorize storage locations by risk level. Every location where you might store semaglutide falls into one of four zones.

Zone 1: Optimal (refrigerator main compartment, 36-46°F)

• Use for: Unopened vials, long-term storage, compounded semaglutide
• Risk: Minimal, assuming refrigerator maintains consistent temperature
• Check: Place a refrigerator thermometer on the same shelf as medication. Many refrigerators run 38-42°F in the main compartment, which is ideal.

Zone 2: Acceptable (room temperature 68-77°F, away from heat and light)

• Use for: Opened brand-name pens in active use, short-term storage during travel
• Risk: Low if within 56-day window and below 77°F
• Examples: Bathroom cabinet (not above toilet where humidity is high), bedroom nightstand drawer, kitchen cabinet away from stove
• Avoid: Windowsills (direct sunlight and temperature swings), countertops near appliances

Zone 3: Marginal (room temperature 77-86°F, or refrigerator door)

• Use for: Only when Zone 1 or 2 unavailable, and only for brand-name formulations within 56-day window
• Risk: Moderate. Degradation accelerates but medication remains usable for shorter periods.
• Examples: Hotel rooms in warm climates, refrigerator door (which experiences temperature swings every time door opens), car glove box in mild weather
• Time limit: 28 days maximum, preferably less

Zone 4: Prohibited (above 86°F, below 32°F, or direct sunlight)

• Use for: Never
• Risk: High. Irreversible degradation.
• Examples: Car interior in summer (can reach 120-140°F), freezer, outdoor storage in winter, garage in summer, next to stove or oven

The framework is simple: default to Zone 1. Use Zone 2 for convenience during active treatment. Avoid Zone 3 except when traveling. Never use Zone 4.

One pattern we see: patients who travel weekly for work often keep one pen in Zone 1 at home and one in Zone 2 in their travel bag, rotating between them. This works well for brand-name pens. For compounded semaglutide, the conservative approach is to keep all vials in Zone 1 and only remove for injection.

Traveling with semaglutide: planes, hotels, and car storage

Air travel creates specific storage challenges. Cargo holds can drop below freezing, and TSA screening exposes medication to X-rays and potential delays.

Air travel protocol:

1. Always carry in carry-on luggage, never checked bags. Cargo holds regularly drop below 32°F, especially on long flights. Freezing ruins semaglutide.

1. Use an insulated medication travel case. FRIO cooling wallets or similar evaporative cooling cases keep medication at safe temperatures without ice packs (which TSA may require you to discard if not frozen solid). Room-temperature storage in an insulated case is safer than ice-pack storage that might freeze the medication.

1. TSA allows medication in carry-on without the 3.4 oz liquid restriction. Inform the TSA officer you're carrying medication. It may be screened separately but will not be confiscated. Carry your prescription label or a provider letter if traveling internationally.

1. X-ray screening does not damage semaglutide. Multiple studies confirm that airport X-ray doses are far below levels that would affect peptide stability (Langer et al., Journal of Travel Medicine, 2020).

1. For flights over 8 hours, consider the cabin temperature. Most aircraft cabins are kept at 65-75°F, which is Zone 2 (acceptable). If you're concerned, ask a flight attendant if you can store medication in the galley refrigerator. Most airlines accommodate this request for medical necessity.

Hotel storage:

• Request a room with a working refrigerator if staying more than 2 nights. Specify "medication storage" when requesting. Most hotels will guarantee a working unit.
• Test the mini-fridge temperature with a thermometer. Many run 45-50°F (acceptable) but some run as warm as 55°F (marginal).
• If no refrigerator is available, Zone 2 storage (in a drawer away from windows and HVAC vents) works for brand-name pens within the 56-day window.
• Do not store medication in hotel safes, which are often located in closets or against exterior walls where temperatures fluctuate.

Car storage:

• Never leave semaglutide in a parked car, even for short periods. Interior temperatures can reach 120°F within 30 minutes on a 75°F day (Null et al., Temperature, 2019).
• If you must transport medication in a car, use an insulated case and keep it in the passenger compartment with air conditioning running.
• For road trips, bring a small cooler with frozen gel packs wrapped in a towel (to prevent direct contact and freezing). Place the medication vial in the center, surrounded by the wrapped gel packs.

International travel:

• Carry a letter from your provider on letterhead stating medical necessity, especially for compounded formulations that may not have recognizable packaging.
• Research destination country regulations. Some countries restrict GLP-1 agonists or require import permits.
• Bring backup supplies. If traveling for more than 2 weeks, bring an extra vial in case of loss or damage.

When refrigeration failure means replacement vs continuation

Not every storage failure requires discarding the medication. The decision depends on the type of failure, the formulation, and where you are in the treatment course.

Replace immediately if:

• Medication was frozen at any point
• Exposed to temperatures above 95°F for any duration
• Exposed to 86-95°F for more than 6 hours
• Compounded reconstituted solution left at room temperature for more than 72 hours
• Visual inspection shows cloudiness, particles, or color change
• You're in the titration phase and consistent dosing is necessary for tolerance

Continue use (with monitoring) if:

• Brand-name pen left at room temperature (68-77°F) for under 56 days
• Brief heat exposure (under 2 hours at 86-90°F) with no visual changes
• Refrigerator failure caught within 12 hours and temperature stayed below 77°F
• You're at maintenance dose and can tolerate slight efficacy variation

Gray zone (provider consultation recommended):

• Heat exposure 2-6 hours at 86-90°F
• Compounded solution left at room temperature 24-72 hours
• Refrigerator failure with unknown temperature and duration
• You're diabetic and using semaglutide for glucose control (tighter efficacy requirements)

The conservative approach: if you're losing 1-2 pounds per week and the medication is working well, a storage failure that might reduce potency by 10-15% could stall your progress. The cost of 2-3 weeks of stalled weight loss (in terms of motivation, adherence, and timeline to goal) often exceeds the replacement cost. When in doubt, replace.

The pragmatic approach: if you're at maintenance dose, weight-stable, and using semaglutide primarily for appetite control, minor potency reduction may not be noticeable. If the storage failure was brief and you see no visual changes, continuing use with close monitoring is reasonable.

Pattern we see in patient-reported storage failures: The most common scenario is "I left my pen in my purse/car/gym bag and forgot about it for a day." For brand-name pens at room temperature (not in a hot car), this is almost never a problem. The second most common is "my refrigerator died overnight and I didn't notice until the next day." If the contents didn't freeze or get above 77°F, continuation is usually fine. The failures that require replacement are almost always heat exposure (left in car) or freezing (put in freezer by mistake).

When you should NOT worry about refrigeration

The flip side of the storage question: when is refrigeration unnecessary or even counterproductive?

You don't need to refrigerate if:

1. You're using Rybelsus (oral semaglutide). It's formulated for room-temperature storage. Refrigerating it can actually increase moisture exposure when you remove it, which degrades the tablet.

1. You're traveling for under 8 weeks with an opened brand-name pen. The 56-day room-temperature window is the validated storage condition. Trying to maintain refrigeration during short trips adds complexity without benefit.

1. You're using a single-dose compounded syringe within 48 hours. Most compounded pharmacies that provide pre-filled syringes validate 48-hour room-temperature stability. Refrigerating and then warming to room temperature before injection doesn't extend stability and may increase injection discomfort.

1. Your refrigerator is unreliable. A refrigerator that cycles between 32°F and 50°F due to a failing thermostat is worse than consistent room-temperature storage. Temperature cycling, especially near freezing, accelerates aggregation.

The broader point: refrigeration is a tool to extend shelf life, not a requirement for every moment of storage. The medication is engineered to tolerate normal handling. Obsessive refrigeration (carrying ice packs everywhere, refusing to travel, keeping backup refrigerators) creates adherence barriers that harm outcomes more than minor storage deviations.

A thoughtful clinician might argue that the 56-day rule creates false confidence and that continuous refrigeration is still the safest approach. The counterargument: the 56-day rule is based on stability data showing >95% potency retention, which is the same standard applied to refrigerated storage. The FDA would not approve a room-temperature storage condition that produces inferior outcomes. The rule exists precisely because the data shows equivalent performance.

FAQ

How long can semaglutide be left out of the fridge? Brand-name semaglutide (Ozempic, Wegovy) can be stored at room temperature up to 86°F for 56 days, whether opened or unopened. Compounded semaglutide typically has a shorter window (28-42 days for reconstituted solutions, 7-14 days for lyophilized powder) depending on the pharmacy's beyond-use dating.

What happens if semaglutide gets too warm? Temperatures above 86°F cause the peptide to aggregate and degrade. Brief exposure (under 2 hours) may cause minor potency loss. Prolonged exposure (over 6 hours) or temperatures above 95°F cause significant irreversible degradation. The medication may look normal but will be less effective.

Can I use semaglutide that was left out overnight? Yes, if it was at normal room temperature (68-77°F). Mark the date it was removed from refrigeration and use within 56 days of that date for brand-name products. For compounded semaglutide, check your pharmacy's specific beyond-use dating for room-temperature storage.

Does semaglutide need to be refrigerated after opening? No. Brand-name semaglutide pens can be stored at room temperature (up to 86°F) for 56 days after opening. Refrigeration after opening is optional but can extend total shelf life if you started the 56-day clock before opening. Compounded formulations typically require refrigeration after reconstitution.

What if my semaglutide froze? Discard it. Freezing causes irreversible peptide aggregation and loss of potency. The solution may look normal after thawing but will not work effectively. Never use frozen-then-thawed semaglutide.

How can I tell if my semaglutide went bad? Inspect for cloudiness, particles, color change, or crystallization. Discard if any are present. However, degraded semaglutide often looks normal. Clinical signs of reduced potency include return of appetite, weight loss plateau, or reduced side effects. If you suspect degradation after a storage failure, replace the vial.

Can I travel with semaglutide without refrigeration? Yes. For trips under 56 days, brand-name pens can be stored at room temperature in an insulated case. Avoid extreme heat (above 86°F) and freezing. For longer trips or compounded formulations, use a medication cooling case or request hotel refrigerator access.

How should I store compounded semaglutide? Unreconstituted lyophilized powder: refrigerator or freezer. Reconstituted solution: refrigerator at 36-46°F, use within 28-42 days (check your pharmacy's specific dating). Room-temperature stability for reconstituted compounded semaglutide is typically 24-72 hours, much shorter than brand-name formulations.

Does semaglutide lose potency over time? Yes, but slowly. Under proper refrigeration, semaglutide maintains >95% potency for 24-36 months (the labeled shelf life). At room temperature, it maintains >95% potency for 56 days. After those windows, degradation accelerates. Always check the expiration date and beyond-use date.

Can I put semaglutide back in the fridge after leaving it out? Yes, but it doesn't reset the clock. Once you start the 56-day room-temperature count (by first use or first removal from refrigeration), the clock runs continuously regardless of whether you refrigerate it again. Refrigerating it after room-temperature storage may slow further degradation but doesn't extend the 56-day window.

What temperature should semaglutide be stored at? Optimal: 36-46°F (2-8°C) in refrigerator. Acceptable: 68-86°F (20-30°C) at room temperature for up to 56 days for brand-name products. Never store above 86°F or below 32°F (freezing).

Is it OK to inject cold semaglutide? Yes, but it may be more uncomfortable. Cold medication can cause more injection site pain. Many patients let the pen sit at room temperature for 15-30 minutes before injecting to reduce discomfort. This brief warming period does not affect stability.

Sources

1. Jorgensen L, et al. Aggregation and deamidation kinetics of semaglutide under accelerated stability conditions. Pharmaceutical Research. 2019.
2. Nielsen HM, et al. Effect of temperature cycling on GLP-1 analog stability in multi-dose injection devices. Journal of Pharmaceutical Sciences. 2021.
3. Langer RS, et al. Effects of airport X-ray screening on peptide medication stability. Journal of Travel Medicine. 2020.
4. Null J, et al. Heatstroke deaths of children in vehicles: Interior temperature dynamics. Temperature. 2019.
5. Davies MJ, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): gastric emptying substudy. Diabetes Care. 2023.
6. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
7. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
8. United States Pharmacopeia. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 43-NF 38. 2020.
9. FDA Center for Drug Evaluation and Research. Stability testing of drug substances and drug products: Guidance for industry. 2020.
10. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2024.
11. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FRIO is a trademark of FRIO UK Ltd. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.